Hologic, Inc. (HOLX) |
75.1 0.18 (0.24%) 04-18 16:00 |
Open: | 74.97 |
High: | 75.235 |
Low: | 74.53 |
Volume: | 1,447,139 |
Market Cap: | 17,628(M) |
PE Ratio: | 35.59 |
Exchange: | NASDAQ Global Select |
Industry: | Medical - Instruments & Supplies |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 79.22 |
Resistance 1: | 77.41 |
Pivot price: | 76.94 |
Support 1: | 74.47 |
Support 2: | 61.96 |
52w High: | 87.88 |
52w Low: | 64.02 |
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
EPS | 2.110 |
Book Value | 19.840 |
PEG Ratio | 2.61 |
Gross Profit | 0.000 |
Profit Margin (%) | 12.98 |
Operating Margin (%) | 22.38 |
Return on Assets (ttm) | 6.5 |
Return on Equity (ttm) | 10.6 |
Thu, 18 Apr 2024
Are Investors Undervaluing Hologic (HOLX) Right Now? - Yahoo Movies Canada
Wed, 17 Apr 2024
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Wed, 17 Apr 2024
Hologic (HOLX) to Report Q2 Earnings: What's in the Cards? - Yahoo Finance
Wed, 17 Apr 2024
Hologic (HOLX) Q1 Earnings Beat Estimates, 2023 View Up - Yahoo Movies UK
Mon, 15 Apr 2024
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
Fri, 12 Apr 2024
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |